SVA Stock Summary and Trading Ideas (Sinovac Biotech Ltd. - Ordinary Shares (Antigua/Barbudo) | NASDAQ:SVA)

Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.

Sinovac Biotech Ltd. - Ordinary Shares (Antigua/Barbudo) trades on the NASDAQ stock market under the symbol SVA.

As of December 19, 2025, SVA stock price was flat at $6.47 with million shares trading.

SVA has a market cap of $464.94 million. This is considered a Small Cap stock.

In the last 3 years, SVA traded as high as $6.47 and as low as $6.47.

SVA has outperformed the market in the last year with a price return of +2550.2% while the SPY ETF gained +18.1%. However, in the short term, SVA had mixed performance relative to the market. It has underperformed in the last 3 months, returning 0.0% vs +2.8% return in SPY. But in the last 2 weeks, SVA shares have fared better than the market returning 0.0% compared to SPY -0.5%.

SVA support price is $6.47 and resistance is $6.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SVA shares will trade within this expected range on the day.